News and breakthroughs in tissue analysis, biomarkers, and pathology technology.
FDA’s Proposed Policy in Companion Diagnostics
On July 12, 2011, the FDA released a new draft guidance on the development and review of companion diagnostics (CDx). I would encourage anyone working in
Measurement of beta cell mass with stereology
Stereology in primate pancreas analysis presented at the 2011 Society of Toxicologic Pathology meeting Flagstaff, AZ (07/01/2011) — Flagship Biosciences, a quantitative pathology services company,
Killer App Discovered in Digital Pathology
8 August 2011 — Fenway, MA. After many years of anticipation, a killer application has finally been discovered for digital pathology, by researchers at the
Dr. David Eberhard joins Flagship as Chief Medical Pathologist
Pharmaceutical veteran anatomic pathologist strengthens Flagship’s expertise in oncology and clinical trials Flagstaff, AZ (04/26/2011) —Flagship Biosciences announced today that Dr. David Eberhard MD, PhD
University of Minnesota licenses multiplexing software to Flagship Biosciences
Flagship receives exclusive license to software that pairs quantitative techniques with pathology expertise MINNEAPOLIS / ST. PAUL (04/14/2011) —The University of Minnesota has finalized a
Flagship Biosciences launches Bridge Staining, combining brightfield and fluorescence whole slide scanning
The novel staining approach combines the multiplexing capabilities of fluorescence with the tissue context of brightfield whole slide scanning FLAGSTAFF, Ariz. — March 17, 2011
